announces its participation at the 2024 American Association for Cancer Research (AACR) Annual Meeting on April 5-10, San Diego, where it will present results of preclinical studies of TSN1611(Poster# 3315), a pot...
American Association for Cancer Research® (AACR) Annual Meeting 2024 Posters87 Integrated Pipeline for Immuno-Oncology Drug Testing: From Patient-Derived Organoid Assays with Reconstituted TME to Fresh Ex Vivo Patient Tissue Cultures Session Category: ImmunologyAuthors: Nataliia Beztsinna Read Poster ...
Poster Board Number: 6 GPCRpanel establishment and application in drug discovery Presenter: TJ Bing Time: Tuesday Apr 9, 2024 9:00 AM - 12:30 PM Location: Poster Section 14 Poster Board Number: 7 A WRN screening cascade to facilitate novel drug discovery Presenter: TJ Bing Time: Tuesday Ap...
2024年美国癌症研究协会年会 (AACR ANNUAL MEETING 2024)于当地时间4月5日-10日在美国圣地亚哥召开。在本次会议上,映恩生物以壁报形式公布基于其自主研发的抗肿瘤ADC平台DITAC (Duality Immune Toxin Antibody Conjugate)开发的DB-1310、DB-1311创新项目的研究成果,信息如下: 壁报信息1 Title: A Phase 1/2a, multic...
The 115th American Association for Cancer Research (AACR) Annual Meeting was held in San Diego, USA, April 5-10, 2024. The AACR Annual Meeting, as one of the leading cancer conferences in the world, has always been a focus of attention in the global pharmaceutical industry. The themeof ...
2024年度美国临床肿瘤学会年会(2024 ASCO Annual Meeting)将于2024年5月31日至6月4日在美国芝加哥市举行。 迈华替尼期关键性临床研究(HDHY-MHTN-III-1907)阳性结果入选大会POSTER,口服PTPN2 小分子抑制剂 HDM2010 研究入选大会摘要。 迈华替尼 摘要标题:Mefatinib as first-line treatment of EGFR sensitizing ...
“Company”) today announced that two preclinical researches have been selected in Late-Breaking Research 2024 AACR(American Association for Cancer Research)Annual Meeting, which will be hold on Apr.5th to 10th, 2024 in San Diego, CA. As the focus of cancer research community, this meeting ...
antibody therapeutics for cancer and immune diseases using single-cell sequencing technologies, today announced a poster presentation of preclinical data from IL1RAP mAb at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2024 taking place April 5-10 in San Diego, California...
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, presented the preclinical research findings of three potential novel drug candidates in poster format at the American Association for Cancer Research (AACR) Annual Meeting, held from April 5 to 10, 2024. ...
“Company”), a clinical-stage biopharmaceutical company developing medicines to address difficult-to-treat cancers, presented two posters at the 2024 American Association for Cancer Research (AACR) Annual Meeting, held April 5-10, 2024 in San Diego, Calif. Copies of the posters are available on...